| Literature DB >> 24119781 |
Katalin Szakszon1, István Szegedi2, Agnes Magyar2, Eva Oláh2, Mónika Andrejkovics3, Petra Balla3, András Lengyel4, Ervin Berényi5, István Balogh6.
Abstract
Niemann-Pick disease type C is a rare lipid trafficking disorder characterized by the accumulation of cholesterol and glycosphingolipids in the brain and viscera. Perinatal, early infantile, late infantile, juvenile and adult forms are distinguished based on the age of manifestation. In the juvenile form, patients in their early years are usually, but not always, symptom free, but present with neurodegeneration later in their lives. These include clumsiness, ataxia, seizures, motor and intellectual decline. Psychiatric manifestations may occur at any stage of the disease. These manifestations include schizophrenia, presenile dementia, depression or psychosis. In 2009, miglustat was approved for the therapy of the disease. We present a case of a patient with juvenile Niemann-Pick C disease whose psychosis was reversed completely by miglustat treatment. Based on our clinical experience we suggest considering Niemann-Pick C in cases of therapy-resistant psychosis and encourage the introduction of miglustat in Niemann-Pick C patients even in the most advanced cases, with respect to psychiatric illness.Entities:
Keywords: Cerebral atrophy; Miglustat; Niemann–Pick C; Psychosis
Mesh:
Substances:
Year: 2013 PMID: 24119781 DOI: 10.1016/j.ejpn.2013.08.002
Source DB: PubMed Journal: Eur J Paediatr Neurol ISSN: 1090-3798 Impact factor: 3.140